Items where authors include "Gamble, C."

Article

Sidhu, J.K., Siggins, M.K. orcid.org/0000-0003-2504-6518, Liew, F. orcid.org/0000-0002-8736-9198 et al. (400 more authors) (2024) Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19. The Journal of Infectious Diseases, 230 (1). e17-e29. ISSN 0022-1899

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Stocken, D.D. orcid.org/0000-0001-8031-1738, Mossop, H., Armstrong, E. et al. (5 more authors) (2024) Good Statistical Practice—development of tailored Good Clinical Practice training for statisticians. Trials, 25. 113. ISSN 1745-6215

Gamble, C., Lewis, S., Stocken, D. et al. (4 more authors) (2024) Determining a risk-proportionate approach to the validation of statistical programming for clinical trials. Clinical Trials, 21 (1). pp. 85-94. ISSN 1740-7745

Gamble, C., Lewis, S., Stocken, D. et al. (4 more authors) (2024) Determining a risk-proportionate approach to the validation of statistical programming for clinical trials. Clinical Trials, 21 (1). pp. 85-94. ISSN 1740-7745

Toader, A.-M. orcid.org/0000-0002-3801-3486, Campbell, M.K., Quint, J.K. et al. (32 more authors) (2024) Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage. Trials, 25 (1). 94. ISSN 1745-6215

Michael, B.D. orcid.org/0000-0002-8693-8926, Dunai, C. orcid.org/0000-0001-5799-2387, Needham, E.J. orcid.org/0000-0001-7042-7462 et al. (559 more authors) (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14 (1). 8487. ISSN 2041-1723

Goulão, B. orcid.org/0000-0003-1490-7183, Morris, T.P. orcid.org/0000-0001-5850-3610, Blazeby, J. et al. (7 more authors) (2023) Involving patients and the public In sTatistIcal Analysis pLans (INITIAL): a delphi survey. PLOS ONE, 18 (12). e0292257. ISSN 1932-6203

Goldswain, H., Dong, X., Penrice-Randal, R. et al. (405 more authors) (2023) The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection. Genome Biology, 24 (1). 47. ISSN 1474-7596

Roper, K.J., Thomas, J., Albalawi, W. et al. (111 more authors) (2023) Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera. Scientific Reports, 13. 15014. ISSN 2045-2322

Iflaifel, M., Sprange, K., Bell, J. et al. (7 more authors) (2023) Developing guidance for a risk-proportionate approach to blinding statisticians within clinical trials: a mixed methods study. Trials, 24. 71. ISSN 1745-6215

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Iflaifel, M., Partlett, C., Bell, J. et al. (7 more authors) (2022) Blinding of study statisticians in clinical trials : a qualitative study in UK clinical trials units. Trials, 23 (1). 535.

Homer, V., Yap, C., Bond, S. et al. (16 more authors) (2022) Early phase clinical trials extension to guidelines for the content of statistical analysis plans. The BMJ, 376. e068177. ISSN 0959-8138

Avery, K.N.L., Williamson, P.R., Gamble, C. et al. (27 more authors) (2017) Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open, 7. e013537.